Validating the AREDS Simplified Severity Scale of Age-Related Macular Degeneration with 5- and 10-Year Incident Data in a Population-Based Sample

Ophthalmology

Volumn 123, Issue 9, 2016, Pages 1874-1878

  Liew, Gerald ^a   Joachim, Nichole ^a   Mitchell, Paul ^a   Burlutsky, George ^a   Wang, Jie Jin ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; AREDS SIMPLIFIED SEVERITY SCALE; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); DRUSEN; GEOGRAPHIC ATROPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PIGMENT DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RISK FACTOR; STEREOSCOPIC VISION; SUBRETINAL NEOVASCULARIZATION; VALIDATION STUDY; AUSTRALIA; CHOROIDAL NEOVASCULARIZATION; CLASSIFICATION; COMPARATIVE STUDY; FOLLOW UP; MACULAR DEGENERATION; MALE; MIDDLE AGED; PATHOLOGY; RETINAL DRUSEN; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; CHOROIDAL NEOVASCULARIZATION; FOLLOW-UP STUDIES; GEOGRAPHIC ATROPHY; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL DRUSEN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84982266758     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.05.043     Document Type: Article

References (14)

1. 1 Ferris, F.L., Davis, M.D., Clemons, T.E., et al. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123 (2005), 1570–1574.
2. 2 Ferris, F.L. III, Wilkinson, C.P., Bird, A., et al. Clinical classification of age-related macular degeneration. Ophthalmology 120 (2013), 844–851.
3. 3 Davis, M.D., Gangnon, R.E., Lee, L.Y., et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol 123 (2005), 1484–1498.
4. 4 Sallo, F.B., Peto, T., Leung, I., et al. The international classification system and the progression of age-related macular degeneration. Curr Eye Res 34 (2009), 238–240.
5. 5 Klein, R., Meuer, S.M., Myers, C.E., et al. Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium. Ophthalmic Epidemiol 21 (2014), 14–23.
6. 6 You, Q.S., Xu, L., Yang, H., et al. Five-year incidence of age-related macular degeneration: the Beijing Eye Study. Ophthalmology 119 (2012), 2519–2525.
7. 7 Bird, A.C., Bressler, N.M., Bressler, S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995), 367–374.
8. 8 Mitchell, P., Smith, W., Attebo, K., Wang, J.J., Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102 (1995), 1450–1460.
9. 9 Mitchell, P., Wang, J.J., Foran, S., Smith, W., Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109 (2002), 1092–1097.
10. 10 A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001), 1417–1436.
11. 11 Klein, R., Davis, M., Magli, Y., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (1991), 1128–1134.
12. 12 The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. The Age-Related Eye Disease Study Research Group. Control Clin Trials 20 (1999), 573–600.
13. 13 Chew, E.Y., Clemons, T.E., Agron, E., et al. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol 132 (2014), 272–277.
14. 14 Ying, G.S., Maguire, M.G., Alexander, J., et al. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-Related Macular Degeneration Prevention Trial. Arch Ophthalmol 127 (2009), 1147–1151.